Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol, Version 6, 08 Jul 2020, MHRA
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
G. Organisation Responsibilities
Appendix I - Expectations for Specific Serious Breach Topics
Appendix II Examples of Serious Breaches Notified to MHRA (this is not an exhaustive list)
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
다가오는 임상 시험
-
National Institute of Medical Sciences and Nutrition...아직 모집하지 않음RhA - 류마티스 관절염
-
Institute of Liver and Biliary Sciences, India아직 모집하지 않음
-
Centre Leon Berard아직 모집하지 않음
-
Casa di Cura Privata 'Malzoni - Villa dei Platani...모병
-
Assembly Biosciences아직 모집하지 않음
-
Cerenovus, Part of DePuy Synthes Products, Inc.아직 모집하지 않음
-
AstraZenecaDaiichi Sankyo아직 모집하지 않음전이성 유방암 | HER2 양성 유방암 | 절제 불가능한 유방암 | HER2-저발현 유방암캐나다